Author Correction: A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals

Affiliations

¹ TechnoPhage, SA, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.
² Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, 1649-028, Lisboa, Portugal.
³ Instituto de Medicina Molecular e Instituto de Histologia e Biologia do Desenvolvimento, Faculdade de Medicina da Universidade de Lisboa, 1649-028, Lisboa, Portugal. msaude@medicina.ulisboa.pt.

Published Erratum

Diana Chapela et al. Sci Rep. 2020.

. 2020 Jan 15;10(1):749.

doi: 10.1038/s41598-020-57443-7.

¹ TechnoPhage, SA, Av. Prof. Egas Moniz, 1649-028, Lisboa, Portugal.
² Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, 1649-028, Lisboa, Portugal.
³ Instituto de Medicina Molecular e Instituto de Histologia e Biologia do Desenvolvimento, Faculdade de Medicina da Universidade de Lisboa, 1649-028, Lisboa, Portugal. msaude@medicina.ulisboa.pt.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammals.
Chapela D, Sousa S, Martins I, Cristóvão AM, Pinto P, Corte-Real S, Saúde L. Chapela D, et al. Sci Rep. 2019 Jul 19;9(1):10475. doi: 10.1038/s41598-019-47006-w. Sci Rep. 2019. PMID: 31324865 Free PMC article.

1. Tep C, et al. Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury. J Neurosci. 2013;33:397–410. doi: 10.1523/JNEUROSCI.0399-12.2013. - DOI - PMC - PubMed
1. Hoschouer EL, Finseth T, Flinn S, Basso DM, Jakeman LB. Sensory stimulation prior to spinal cord injury induces post-injury dysesthesia in mice. J Neurotrauma. 2010;27:777–787. doi: 10.1089/neu.2009.1182. - DOI - PMC - PubMed